{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:13:48Z","timestamp":1777407228436,"version":"3.51.4"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Primary aldosteronism is the most common surgically curable form of hypertension. The sporadic forms of the disorder are usually caused by aldosterone overproduction from a unilateral adrenocortical aldosterone-producing adenoma or from bilateral adrenocortical hyperplasia. The main knowledge-advances in disease pathophysiology focus on pathogenic germline and somatic variants that drive the excess aldosterone production. Less clear are the molecular and cellular mechanisms that lead to an increased mass of the adrenal cortex. However, the combined application of transcriptomics, metabolomics, and epigenetics has achieved substantial insight into these processes and uncovered the evolving complexity of disrupted cell growth mechanisms in primary aldosteronism. In this review, we summarize and discuss recent progress in our understanding of mechanisms of cell death, and proliferation in the pathophysiology of primary aldosteronism.<\/jats:p>","DOI":"10.3389\/fendo.2022.934326","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T05:46:20Z","timestamp":1659937580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation"],"prefix":"10.3389","volume":"13","author":[{"given":"Martina","family":"Tetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tem.2021.10.002","article-title":"Pathophysiology and histopathology of primary aldosteronism","volume":"33","author":"Williams","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0377","article-title":"A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma","volume":"181","author":"Dutta","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","article-title":"GNAS mutations in adrenal aldosterone-producing adenomas","volume":"63","author":"Nakajima","year":"2016","journal-title":"Endocr J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in white americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa595","article-title":"Prevalence of somatic mutations in aldosterone-producing adenomas in Japanese patients","volume":"105","author":"Nanba","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa123","article-title":"Identification of somatic mutations in CLCN2 in aldosterone-producing adenomas","volume":"4","author":"Rege","year":"2020","journal-title":"J Endocr Soc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17348","article-title":"Single-center prospective cohort study on the histopathology, genotype, and postsurgical outcomes of patients with primary aldosteronism","volume":"78","author":"Meyer","year":"2021","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 k(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.683588","article-title":"Approaches to gene mutation analysis using formalin-fixed paraffin-embedded adrenal tumor tissue from patients with primary aldosteronism","volume":"12","author":"Nanba","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa367","article-title":"Biochemical, histopathological, and genetic characterization of posture-responsive and unresponsive APAs","volume":"105","author":"Guo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13476","article-title":"Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth","volume":"74","author":"Yang","year":"2019","journal-title":"Hypertension"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","article-title":"Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas","volume":"63","author":"Williams","year":"2014","journal-title":"Hypertension"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na(+)\/K(+)-ATPase","volume":"156","author":"Stindl","year":"2015","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.221315298","article-title":"Ouabain, a steroid hormone that signals with slow calcium oscillations","volume":"98","author":"Aizman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-05-0427","article-title":"Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility","volume":"16","author":"Barwe","year":"2005","journal-title":"Mol Biol Cell"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e05-08-0735","article-title":"Binding of src to Na+\/K+-ATPase forms a functional signaling complex","volume":"17","author":"Tian","year":"2006","journal-title":"Mol Biol Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010981","article-title":"ATP1A1 mutant in aldosterone-producing adenoma leads to cell proliferation","volume":"22","author":"Kobuke","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/srep39121","article-title":"The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3521","article-title":"The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer","volume":"13","author":"O'Hayre","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31724","article-title":"GNAQ, and GNA11 alterations in patients with diverse cancers","volume":"124","author":"Parish","year":"2018","journal-title":"Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01248","article-title":"Multiple targets of the canonical WNT\/\u03b2-catenin signaling in cancers","volume":"9","author":"Lecarpentier","year":"2019","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040409","article-title":"Update on genetics of primary aldosteronism","volume":"9","author":"Itcho","year":"2021","journal-title":"Biomedicines"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1205","article-title":"Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem\/progenitor cell markers","volume":"152","author":"Boulkroun","year":"2011","journal-title":"Endocrinology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa616","article-title":"RNA Sequencing and somatic mutation status of adrenocortical tumors: Novel pathogenetic insights","volume":"105","author":"Di Dalmazi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13834","article-title":"Armc5 deletion causes developmental defects and compromises T-cell immune responses","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx235","article-title":"Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function","volume":"26","author":"Berthon","year":"2017","journal-title":"Hum Mol Genet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2015.98","article-title":"ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions","volume":"30","author":"Mulatero","year":"2016","journal-title":"J Hum Hypertens"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab682","article-title":"Targeted mutational analysis of cortisol-producing adenomas","volume":"107","author":"Rege","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.186205","article-title":"Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits","volume":"59","author":"Gomez-Sanchez","year":"2012","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00189","article-title":"Genetic causes of functional adrenocortical adenomas","volume":"38","author":"Zennaro","year":"2017","journal-title":"Endocr Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011148","article-title":"The cyclic AMP pathway","volume":"4","author":"Sassone-Corsi","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nat Genet"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.11.018","article-title":"How does cAMP\/protein kinase a signaling lead to tumors in the adrenal cortex and other tissues","volume":"336","author":"Almeida","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02209","article-title":"Somatic PRKACA mutations: Association with transition from pituitary-dependent to adrenal-dependent cushing syndrome","volume":"104","author":"Di Dalmazi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1295-4","article-title":"Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series","volume":"58","author":"Fallo","year":"2017","journal-title":"Endocrine"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041124","article-title":"Comparative genomics and transcriptome profiling in primary aldosteronism","volume":"19","author":"Aristizabal Prada","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215582","article-title":"Transcriptomics, epigenetics, and metabolomics of primary aldosteronism","volume":"13","author":"Spyroglou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1309","article-title":"Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis","volume":"90","author":"Assi\u00e9","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.150318","article-title":"Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro","volume":"55","author":"Williams","year":"2010","journal-title":"Hypertension"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","article-title":"Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis","volume":"59","author":"Williams","year":"2012","journal-title":"Hypertension"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1038\/oncsis.2015.20","article-title":"Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of \u03b2-catenin in adrenocortical carcinoma","volume":"4","author":"Lef\u00e8vre","year":"2015","journal-title":"Oncogenesis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1038\/s41598-019-41525-2","article-title":"RNA Sequencing provides novel insights into the transcriptome of aldosterone producing adenomas","volume":"9","author":"Backman","year":"2019","journal-title":"Sci Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16774","article-title":"BEX1 is differentially expressed in aldosterone-producing adenomas and protects human adrenocortical cells from ferroptosis","volume":"77","author":"Yang","year":"2021","journal-title":"Hypertension"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08033","article-title":"Transcriptome pathway analysis of pathological and physiological aldosterone-producing human tissues","volume":"68","author":"Zhou","year":"2016","journal-title":"Hypertension"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09231","article-title":"NEFM (Neurofilament medium) polypeptide, a marker for zona glomerulosa cells in human adrenal, inhibits D1R (Dopamine D1 receptor)-mediated secretion of aldosterone","volume":"70","author":"Maniero","year":"2017","journal-title":"Hypertension"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jsbmb.2013.09.007","article-title":"Hedgehog-signaling is upregulated in non-producing human adrenal adenomas and antagonism of hedgehog-signaling inhibits proliferation of NCI-H295R cells and an immortalized primary human adrenal cell line","volume":"139","author":"Werminghaus","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4098","article-title":"Sonic hedgehog signaling is active in human adrenal cortex development and deregulated in adrenocortical tumors","volume":"99","author":"Gomes","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.06.022","article-title":"YPEL4 modulates HAC15 adrenal cell proliferation and is associated with tumor diameter","volume":"434","author":"Oki","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1734","article-title":"LGR5 activates noncanonical wnt signaling and inhibits aldosterone production in the human adrenal","volume":"100","author":"Shaikh","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/iep.12267","article-title":"MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2","volume":"99","author":"Zhang","year":"2018","journal-title":"Int J Exp Pathol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00746","article-title":"miRNA-203 modulates aldosterone levels and cell proliferation by targeting Wnt5a in aldosterone-producing adenomas","volume":"103","author":"Peng","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12814","article-title":"Downregulation of miR-375 in aldosterone-producing adenomas promotes tumour cell growth via MTDH","volume":"83","author":"He","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1912700116","article-title":"Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis","volume":"116","author":"Belavgeni","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153716","article-title":"Primary aldosteronism: Metabolic reprogramming and the pathogenesis of aldosterone-producing adenomas","volume":"13","author":"Gong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.100438","article-title":"Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis","volume":"50","author":"Lenzini","year":"2007","journal-title":"Hypertension"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0478","article-title":"The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma","volume":"67","author":"Oki","year":"2020","journal-title":"Endocr J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/bies.950170605","article-title":"Calcium signalling and cell proliferation","volume":"17","author":"Berridge","year":"1995","journal-title":"Bioessays"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10205","article-title":"Calneuron 1 increased Ca2+ in the endoplasmic reticulum and aldosterone production in aldosterone-producing adenoma","volume":"71","author":"Kobuke","year":"2018","journal-title":"Hypertension"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14062","article-title":"Endoplasmic reticulum chaperone calmegin is upregulated in aldosterone-producing adenoma and associates with aldosterone production","volume":"75","author":"Itcho","year":"2020","journal-title":"Hypertension"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0194-5","article-title":"Potential important roles and signaling mechanisms of YPEL4 in pulmonary diseases","volume":"7","author":"Truong","year":"2018","journal-title":"Clin Transl Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00145.2007","article-title":"Gene expression profile in rat adrenal zona glomerulosa cells stimulated with aldosterone secretagogues","volume":"32","author":"Romero","year":"2007","journal-title":"Physiol Genomics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.1038\/s41598-019-50988-2","article-title":"Retinoic acid receptor \u03b1 as a novel contributor to adrenal cortex structure and function through interactions with wnt and vegfa signalling","volume":"9","author":"El Zein","year":"2019","journal-title":"Sci Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1055\/a-1129-6947","article-title":"In situ metabolite mass spectrometry imaging: New insights into the adrenal gland","volume":"52","author":"Li","year":"2020","journal-title":"Horm Metab Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00064","article-title":"High-resolution tissue mass spectrometry imaging reveals a refined functional anatomy of the human adult adrenal gland","volume":"159","author":"Sun","year":"2018","journal-title":"Endocrinology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130356","article-title":"In situ metabolomics of aldosterone-producing adenomas","volume":"4","author":"Murakami","year":"2019","journal-title":"JCI Insight"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11243","article-title":"Aldosterone and 18-oxocortisol coaccumulation in aldosterone-producing lesions","volume":"72","author":"Sugiura","year":"2018","journal-title":"Hypertension"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14041","article-title":"Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism","volume":"75","author":"Sun","year":"2020","journal-title":"Hypertension"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/path.4560","article-title":"High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples","volume":"237","author":"Buck","year":"2015","journal-title":"J Pathol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B103","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1055\/a-1128-0421","article-title":"The potential role of aldosterone-producing cell clusters in adrenal disease","volume":"52","author":"Lim","year":"2020","journal-title":"Horm Metab Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: Nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.10.014","article-title":"Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism","volume":"441","author":"Nishimoto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13156","article-title":"Diverse responses of autoantibodies to the angiotensin II type 1 receptor in primary aldosteronism","volume":"74","author":"Williams","year":"2019","journal-title":"Hypertension"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13388","article-title":"AT1AA (Angiotensin II type-1 receptor autoantibodies): Cause or consequence of human primary aldosteronism","volume":"74","author":"Piazza","year":"2019","journal-title":"Hypertension"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3495","article-title":"Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas","volume":"99","author":"Howard","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa585","article-title":"DNA Methylation of steroidogenic enzymes in benign adrenocortical tumors: New insights in aldosterone-producing adenomas","volume":"105","author":"Di Dalmazi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08313","article-title":"Hypomethylation of CYP11B2 in aldosterone-producing adenoma","volume":"68","author":"Yoshii","year":"2016","journal-title":"Hypertension"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0148","article-title":"Integration of transcriptome and methylome analysis of aldosterone-producing adenomas","volume":"173","author":"Murakami","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-016-0893-x","article-title":"Regulatory mechanisms of microRNA expression","volume":"14","author":"Gulyaeva","year":"2016","journal-title":"J Transl Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00739","article-title":"Circulating miRNA expression profiling in primary aldosteronism","volume":"10","author":"Decmann","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B117","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/a-1116-2366","article-title":"MicroRNAs and adrenocortical tumors: Where do we stand on primary aldosteronism","volume":"52","author":"T\u00f6mb\u00f6l","year":"2020","journal-title":"Horm Metab Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.934326\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T05:46:24Z","timestamp":1659937584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.934326\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":117,"alternative-id":["10.3389\/fendo.2022.934326"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.934326","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"article-number":"934326"}}